Research

Rising Demand for Monoclonal Antibodies Drive Growth of Chromatography Resins Market by 2020

Press Release

Chromatography primarily involves processes that enable the separation of mixtures into individual components based on the color. Specialized resins are a crucial component required for the successful application of chromatographic techniques of different kinds including mixed mode, hydrophobic interaction, gel filtration, ion exchange, size exclusion, and affinity.

Resins are widely integrated into chromatography devices, based on the end use application and industry such as food processing, drug development and production, bio molecular testing and health diagnostics. In these applications making the right choice in resins is very important to make sure that accurate and effective separation of individual components is done in the right way.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1349 

The chromatography resins market is highly dependent on the rising demand from end use industries such as pharmaceuticals, food and beverage, biotechnology, cosmetics, and research. Other factors affecting current and future development in the market can include:

  1. The key factor that is driving the demand in the chromatography resins market is the massive demand for monoclonal antibodies, owing to the rise in incidences of chronic diseases, which is boosting the importance of therapeutic products and procedures. This is supported by the strong and sustained activity currently taking place in the fields of pharmaceuticals and biotechnology.
  2. Governments across the world have laid down stringent regulations with regards to production and handling of chromatography resins. This is expected to play a key restrictive role in the market for the foreseeable future. However, the impact of these regulations are expected to be partly offset by new opportunities opening from research and development activities in the field.
  3. Ion exchange chromatography has displayed a relatively higher rate of adoption towards chromatography resins. On the other hand, affinity chromatography procedures are expected to lead the market in terms of revenue owing to higher costs of resins that are associated with affinity processes.
  4. Repeated use of chromatography to lower costs in pharmaceutical development is a major factor that is another factor that has a restrictive effect on the chromatography resins market in terms of technological growth.

Surging demand for chromatography technology from various research & development, and diagnostics industries will drive growth of the global chromatography resins market. Future Market Insights (FMI), in its report, projects the market to register an impressive 8.9% CAGR during the forecast period 2017 to 2027. In 2016, the market was evaluated at revenue worth US$ 719 Mn; by 2027-end it is estimated to reach nearly US$ 2,000 Mn. The global chromatography resins market is anticipated to witness an incremental opportunity of over US$ 1,000 Mn between 2017 and 2027.

Increasing Enhancements in Automation of Sample Handling Processes to Drive Market Growth in North America

Research laboratories and biopharmaceutical companies in North America are increasingly focusing on enhancements in automation of sample handling processes. This is expected to drive demand for high throughput advanced chromatography columns and media, thereby fostering the market growth in this region. In addition, soaring advancements in chromatography technologies for separation & purification of complex bio-substances and bio-molecules will further boost demand for high-end, advanced chromatography resins in North America. However, stringent rules & regulations imposed by the U.S. FDA on new product launches is likely to hinder growth of the market in North America.

Cost-effective purification technology is being highly implemented in Western Europe for separation of enantiomers, isomers and several active pharmaceutical ingredients. This further promotes purity and offers higher productivity to biopharmaceutical industries, which in turn will drive growth of the global chromatography resins market in this region. In addition, increasing availability and demand for branded resin products, which are more costly, are other factors expected to fuel growth of the market in Western Europe. In contrast, continuous evaluations and improvements in novel alternatives to chromatography resins are estimated to impede the market growth in this region.

North America will Remain the Largest Market for Chromatography Resins

North America will remain the largest market for chromatography resins, with sales expected to reach nearly US$ 600 Mn by 2027-end, followed by Western Europe and Asia Pacific Excluding Japan (APEJ). In addition, APEJ is estimated to register fastest expansion at 9.4% CAGR through 2027. Although Middle East & Africa (MEA) accounts for lowest share of the market, this region is expected to be the second-fastest growing market for chromatography resins by 2027-end.

By product type, synthetic chromatography resins are expected to remain preferred in the market, with sales expanding at 9.1% CAGR through 2027. Revenue generated from sales of native chromatography resins in the market will remain low during the forecast period.

Need more information about Report methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1349 

Affinity Chromatography Continues to be the Most-used Technology in the Market

Affinity chromatography will continue to be the most used technology in the global chromatography resins market. Revenue amassed from sales of affinity chromatography technology is expected to reach US$ 679.6 Mn by 2027-end. Hydrophobic interaction chromatography technology and affinity chromatography technology are expected to exhibit parallel expansion at 9.3% CAGR through 2027.

Biopharmaceutical companies will remain the largest end-users of chromatography resins across the globe, followed by academic institutes. Sales of chromatography resins to biopharmaceutical companies is projected to register 9.2% CAGR, to reach nearly US$ 800 Mn in revenue by 2027-end.